Erratum: Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.
Janku F, Angenendt P, Tsimberidou AM, Fu S, Naing A, Falchook GS, Hong DS, Holley VR, Cabrilo G, Wheler JJ, Piha-Paul SA, Zinner RG, Bedikian AY, Overman MJ, Kee BK, Kim KB, Kopetz ES, Luthra R, Diehl F, Meric-Bernstam F, Kurzrock R.
Janku F, et al. Among authors: falchook gs.
Oncotarget. 2015 Sep 15;6(27):24581. doi: 10.18632/oncotarget.5663.
Oncotarget. 2015.
PMID: 26405159
Free PMC article.